Xometry, Inc. Class A Common Stock

Day range

$87.89 – $91.74

Open

$89.94

Prev close

$88.88

Volume

125.77K

Market cap

$5.09B

Shares out

51.12M

P/E

—

P/S

6.31

P/B

8.56

P/FCF

—

ROE

-5.2%

ROA

-2.9%

Debt/Equity

0.55

Div yield

0.00%

As of Oct 23, 2026

• Annual meeting resultsJun 18, 2026

  At the Meeting, the Company's stockholders elected the three persons nominated by the Company's board of directors (the "Board") to serve as Class II directors until the Company's 2029 Annual Meeting of Stockholders and until each director's successor is duly elected and qualified. The Company's stockholders also (1) approved, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement, and (2) ratified the selection of Deloitte and Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.

• Underwriting agreementJun 2, 2026

  Xometry, Inc. (the "Company") entered into an underwriting agreement (the "Underwriting Agreement") with J.P. Morgan Securities LLC and Goldman Sachs & Co. LLC, as representatives of the several underwriters named therein (collectively, the "Underwriters"), relating to the issuance and sale in an underwritten public offering (the "Offering") of 2,647,059 shares of the Company's Class A common stock... The Underwriting Agreement contains customary representations, warranties and agreements by the Company, customary conditions to closing, indemnification obligations of the Company and the Underwriters, including for liabilities under the Securities Act of 1933, as amended, other obligations of the parties and termination provisions.

• Director appointmentMay 21, 2026

  On May 20, 2026 (the "Effective Date"), the Board of Directors (the "Board") of Xometry, Inc. (the "Company") appointed Lukas Biewald to serve as a member of the Board effective as of the Effective Date. Mr. Biewald will serve as a Class I director whose term will expire at the Company's 2028 annual meeting of stockholders. The Board also appointed Mr. Biewald as a member of the Nominating and Corporate Governance Committee, effective as of the Effective Date.

• Private placementMay 8, 2026

  the Company agreed to issue and sell 1,049,759 shares of the Company's Class A common stock to SBI GmbH for an aggregate purchase price of approximately $50,000,000 in a private placement exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended.

• Ceo departureFeb 24, 2026

  On February 20, 2026, Randolph Altschuler notified the Board that he will resign as the Company's Chief Executive Officer, effective on the Effective Date. In addition, on February 20, 2026, the Board approved Mr. Altschuler's appointment as Executive Chair of the Board effective as of the Effective Date, for an indefinite term.

Days to cover

4.5

Short interest

4.57M

Avg volume

1.02M

As of Sep 30, 2026 · reported to FINRA twice monthly.

• Xometry to Participate in Upcoming Investor Conferences
  positiveGlobeNewswire Inc.· Aug 25, 2026
• Xometry Announces Pricing of Public Offering of Class A Common Stock
  positiveGlobeNewswire Inc.· Jun 2, 2026
• Xometry to Participate in Upcoming Investor Conferences
  neutralGlobeNewswire Inc.· Apr 30, 2026
• Xometry Shares Beat the S&P 500 as Insider Sells $1.7 Million
  positiveThe Motley Fool· Jan 11, 2026
• Why a Top Biotech Holder Sold 115,000 Mirum Shares but Still Ended Up With $185 Million on the Line
  positiveThe Motley Fool· Dec 28, 2025